• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一组新冠肺炎患者中的细菌和真菌合并感染及二重感染:来自意大利一家三级医院的真实数据。

Bacterial and Fungal Co-Infections and Superinfections in a Cohort of COVID-19 Patients: Real-Life Data from an Italian Third Level Hospital.

作者信息

Ceccarelli Manuela, Marino Andrea, Pulvirenti Sarah, Coco Viviana, Busà Barbara, Nunnari Giuseppe, Cacopardo Bruno Santi

机构信息

Department of Clinical and Experimental Medicine, Unit of Infectious Diseases, University of Catania, I-95122 Catania, Italy.

Department of Biomedical, Dental, Morphological and Functional Imaging Sciences, Unit of Infectious Diseases, University of Messina, I-98124 Messina, Italy.

出版信息

Infect Dis Rep. 2022 May 12;14(3):372-382. doi: 10.3390/idr14030041.

DOI:10.3390/idr14030041
PMID:35645220
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9149992/
Abstract

The use of immune suppressive drugs combined with the natural immune suppression caused by SARS-CoV-2 can lead to a surge of secondary bacterial and fungal infections. The aim of this study was to estimate the incidence of superinfections in hospitalized subjects with COVID-19. We carried out an observational retrospective single center cohort study. We enrolled patients admitted at the "Garibaldi" hospital for ≥72 h, with a confirmed diagnosis of COVID-19. All patients were routinely investigated for bacterial, viral, and fungal pathogens. A total of 589 adults with COVID-19 were included. A total of 88 infections were documented in different sites among 74 patients (12.6%). As for the etiology, 84 isolates were bacterial (95.5%), while only 4 were fungal (4.5%). A total of 51 episodes of hospital-acquired infections (HAI) were found in 43 patients, with a bacterial etiology in 47 cases (92.2%). Community-acquired infections (CAIs) are more frequently caused by , while HAIs are mostly associated with . A high rate of CAIs and HAIs due to the use of high-dose corticosteroids and long hospital stays can be suspected. COVID-19 patients should be routinely evaluated for infection and colonization. More data about antimicrobial resistance and its correlation with antibiotic misuse in COVID-19 patients are required.

摘要

免疫抑制药物的使用,再加上由严重急性呼吸综合征冠状病毒2(SARS-CoV-2)引起的自然免疫抑制,可能导致继发性细菌和真菌感染激增。本研究的目的是评估住院的2019冠状病毒病(COVID-19)患者中二重感染的发生率。我们开展了一项单中心回顾性观察队列研究。我们纳入了在“加里波第”医院住院≥72小时、确诊为COVID-19的患者。所有患者均接受了细菌、病毒和真菌病原体的常规检测。共纳入589例成年COVID-19患者。74例患者(12.6%)在不同部位共记录到88次感染。至于病因,84株分离菌为细菌(95.5%),而真菌仅4株(4.5%)。43例患者共发现51次医院获得性感染(HAI),其中47例(92.2%)为细菌病因。社区获得性感染(CAI)更常由……引起,而HAI大多与……相关。可以怀疑,高剂量糖皮质激素的使用和长时间住院导致了较高的CAI和HAI发生率。应对COVID-19患者进行感染和定植的常规评估。需要更多关于COVID-19患者抗菌药物耐药性及其与抗生素滥用相关性的数据。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/305c/9149992/f3bf4382a2b1/idr-14-00041-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/305c/9149992/7aa2749e14c3/idr-14-00041-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/305c/9149992/e18eba4ac48f/idr-14-00041-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/305c/9149992/9599e703e628/idr-14-00041-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/305c/9149992/f3bf4382a2b1/idr-14-00041-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/305c/9149992/7aa2749e14c3/idr-14-00041-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/305c/9149992/e18eba4ac48f/idr-14-00041-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/305c/9149992/9599e703e628/idr-14-00041-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/305c/9149992/f3bf4382a2b1/idr-14-00041-g004.jpg

相似文献

1
Bacterial and Fungal Co-Infections and Superinfections in a Cohort of COVID-19 Patients: Real-Life Data from an Italian Third Level Hospital.一组新冠肺炎患者中的细菌和真菌合并感染及二重感染:来自意大利一家三级医院的真实数据。
Infect Dis Rep. 2022 May 12;14(3):372-382. doi: 10.3390/idr14030041.
2
Incidence of co-infections and superinfections in hospitalized patients with COVID-19: a retrospective cohort study.COVID-19 住院患者合并感染和再感染的发生率:一项回顾性队列研究。
Clin Microbiol Infect. 2021 Jan;27(1):83-88. doi: 10.1016/j.cmi.2020.07.041. Epub 2020 Jul 31.
3
Bacterial and fungal coinfection among hospitalized patients with COVID-19: a retrospective cohort study in a UK secondary-care setting.COVID-19 住院患者的细菌和真菌感染:英国二级保健机构中的回顾性队列研究。
Clin Microbiol Infect. 2020 Oct;26(10):1395-1399. doi: 10.1016/j.cmi.2020.06.025. Epub 2020 Jun 27.
4
Risk factors and outcomes of fungal superinfections in patients with severe COVID-19: an observational study from Pisa academic hospital.重症新型冠状病毒肺炎患者真菌二重感染的危险因素及结局:来自比萨学术医院的一项观察性研究
Infez Med. 2023 Mar 1;31(1):55-61. doi: 10.53854/liim-3101-8. eCollection 2022.
5
Bacterial/fungal infection in hospitalized patients with COVID-19 in a tertiary hospital in the Community of Castilla y León, Spain.西班牙卡斯蒂利亚-莱昂自治区一家三级医院中新冠肺炎住院患者的细菌/真菌感染情况。
Enferm Infecc Microbiol Clin (Engl Ed). 2020 Dec 3;40(4):158-65. doi: 10.1016/j.eimc.2020.11.003.
6
Predictors of hospital-acquired bacterial and fungal superinfections in COVID-19: a prospective observational study.预测 COVID-19 患者医院获得性细菌和真菌感染的因素:一项前瞻性观察研究。
J Antimicrob Chemother. 2021 Mar 12;76(4):1078-1084. doi: 10.1093/jac/dkaa530.
7
Characterization of Bacterial and Fungal Infections in Hospitalized Patients With Coronavirus Disease 2019 and Factors Associated With Health Care-Associated Infections.2019年冠状病毒病住院患者的细菌和真菌感染特征以及与医疗保健相关感染相关的因素
Open Forum Infect Dis. 2021 May 5;8(6):ofab201. doi: 10.1093/ofid/ofab201. eCollection 2021 Jun.
8
Improving management and antimicrobial stewardship for bacterial and fungal infections in hospitalized patients with COVID-19.改善新型冠状病毒肺炎住院患者细菌和真菌感染的管理及抗菌药物管理
Ther Adv Infect Dis. 2022 May 14;9:20499361221095732. doi: 10.1177/20499361221095732. eCollection 2022 Jan-Dec.
9
A Retrospective Assessment of Sputum Samples and Antimicrobial Resistance in COVID-19 Patients.COVID-19患者痰液样本及抗菌药物耐药性的回顾性评估
Pathogens. 2023 Apr 19;12(4):620. doi: 10.3390/pathogens12040620.
10
Secondary Bacterial Infection and Clinical Characteristics in Patients With COVID-19 Admitted to Two Intensive Care Units of an Academic Hospital in Iran During the First Wave of the Pandemic.伊朗一所学术医院的两个重症监护病房在大流行第一波期间收治的 COVID-19 患者中的继发性细菌感染和临床特征。
Front Cell Infect Microbiol. 2022 Feb 23;12:784130. doi: 10.3389/fcimb.2022.784130. eCollection 2022.

引用本文的文献

1
Incidence and Risk Factors of Secondary Infections in Critically Ill SARS-CoV-2 Patients: A Retrospective Study in an Intensive Care Unit.重症新型冠状病毒肺炎患者继发感染的发生率及危险因素:重症监护病房的一项回顾性研究
Biomedicines. 2025 May 29;13(6):1333. doi: 10.3390/biomedicines13061333.
2
Candidemia Following Severe COVID-19 in Hospitalised and Critical Ill Patients: A Systematic Review and Meta-Analysis.COVID-19 住院和重症患者并发念珠菌血症:系统评价和荟萃分析。
Mycoses. 2024 Oct;67(10):e13798. doi: 10.1111/myc.13798.
3
The Interplay between Airway Cilia and Coronavirus Infection, Implications for Prevention and Control of Airway Viral Infections.

本文引用的文献

1
Ampicillin Plus Ceftriaxone Regimen against Endocarditis: A Literature Review.氨苄西林联合头孢曲松治疗心内膜炎的方案:文献综述
J Clin Med. 2021 Oct 6;10(19):4594. doi: 10.3390/jcm10194594.
2
Bacterial infections and death among patients with Covid-19 versus non Covid-19 patients with pneumonia.新冠病毒感染患者与非新冠病毒感染肺炎患者的细菌感染和死亡情况。
Am J Emerg Med. 2022 Jan;51:1-5. doi: 10.1016/j.ajem.2021.09.040. Epub 2021 Sep 28.
3
High rate of bacterial respiratory tract co-infections upon admission amongst moderate to severe COVID-19 patients.
气道纤毛与冠状病毒感染的相互作用及其对气道病毒感染防控的意义。
Cells. 2024 Aug 14;13(16):1353. doi: 10.3390/cells13161353.
4
The long Pentraxin PTX3 serves as an early predictive biomarker of co-infections in COVID-19.长型 Pentraxin PTX3 可作为 COVID-19 合并感染的早期预测性生物标志物。
EBioMedicine. 2024 Jul;105:105213. doi: 10.1016/j.ebiom.2024.105213. Epub 2024 Jun 21.
5
Bacterial coinfection and antibiotic resistance in hospitalized COVID-19 patients: a systematic review and meta-analysis.COVID-19 住院患者的细菌合并感染和抗生素耐药性:系统评价和荟萃分析。
PeerJ. 2023 Apr 26;11:e15265. doi: 10.7717/peerj.15265. eCollection 2023.
6
A Retrospective Assessment of Sputum Samples and Antimicrobial Resistance in COVID-19 Patients.COVID-19患者痰液样本及抗菌药物耐药性的回顾性评估
Pathogens. 2023 Apr 19;12(4):620. doi: 10.3390/pathogens12040620.
7
/ Mixed Infection in Hematologic Patient with COVID-19 Complications: An Unfortunate Combination./ 新冠肺炎并发症血液学患者的混合感染:一种不幸的组合
Pathogens. 2023 Feb 12;12(2):304. doi: 10.3390/pathogens12020304.
8
The Role of Bacterial and Fungal Superinfection in Critical COVID-19.细菌和真菌感染在重症 COVID-19 中的作用。
Viruses. 2022 Dec 14;14(12):2785. doi: 10.3390/v14122785.
9
Secondary Infections in Critically Ill Patients with COVID-19: A Retrospective Study.COVID-19 危重症患者的继发性感染:一项回顾性研究
Antibiotics (Basel). 2022 Nov 11;11(11):1598. doi: 10.3390/antibiotics11111598.
10
Multidrug resistant bacterial infections in severely ill COVID-19 patients admitted in a national referral and teaching hospital, Kenya.肯尼亚一家国家转诊和教学医院收治的重症 COVID-19 患者中的耐多药细菌感染。
BMC Infect Dis. 2022 Nov 22;22(1):877. doi: 10.1186/s12879-022-07885-3.
高比例的细菌呼吸道合并感染发生于中度至重度 COVID-19 患者入院时。
Infect Dis (Lond). 2022 Feb;54(2):134-144. doi: 10.1080/23744235.2021.1985732. Epub 2021 Oct 4.
4
Respiratory co-and superinfections in COVID-19.COVID-19 中的呼吸道合并与继发感染。
Rev Esp Quimioter. 2021 Sep;34 Suppl 1(Suppl1):69-71. doi: 10.37201/req/s01.20.2021. Epub 2021 Sep 30.
5
Clinical significance of inflammatory markers of bacterial infection in critically ill patients with COVID-19 after treatment with anti-inflammatory and immunomodulatory drugs: a complex new scenario.治疗新冠肺炎危重症患者使用抗炎和免疫调节药物后细菌感染炎症标志物的临床意义:一个复杂的新情况。
Front Biosci (Landmark Ed). 2021 Sep 30;26(9):405-408. doi: 10.52586/4954.
6
Overview on the Prevalence of Fungal Infections, Immune Response, and Microbiome Role in COVID-19 Patients.新冠病毒感染患者真菌感染的患病率、免疫反应及微生物群作用概述
J Fungi (Basel). 2021 Sep 2;7(9):720. doi: 10.3390/jof7090720.
7
A Study in a Regional Hospital of a Mid-Sized Spanish City Indicates a Major Increase in Infection/Colonization by Carbapenem-Resistant Bacteria, Coinciding with the COVID-19 Pandemic.西班牙一座中等规模城市的一家地区医院的一项研究表明,耐碳青霉烯类细菌的感染/定植大幅增加,这与新冠疫情同时发生。
Antibiotics (Basel). 2021 Sep 18;10(9):1127. doi: 10.3390/antibiotics10091127.
8
Procalcitonin to Guide Antibacterial Prescribing in Patients Hospitalised with COVID-19.降钙素原指导COVID-19住院患者的抗菌药物处方
Antibiotics (Basel). 2021 Sep 17;10(9):1119. doi: 10.3390/antibiotics10091119.
9
High Prevalence of Antibiotic Resistance among Opportunistic Pathogens Isolated from Patients with COVID-19 under Mechanical Ventilation: Results of a Single-Center Study.机械通气的新冠肺炎患者分离出的机会性病原体中抗生素耐药性的高流行率:一项单中心研究结果
Antibiotics (Basel). 2021 Sep 6;10(9):1080. doi: 10.3390/antibiotics10091080.
10
Incidence, Risk Factors and Impact on Clinical Outcomes of Bloodstream Infections in Patients Hospitalised with COVID-19: A Prospective Cohort Study.COVID-19住院患者血流感染的发病率、危险因素及对临床结局的影响:一项前瞻性队列研究
Antibiotics (Basel). 2021 Aug 24;10(9):1031. doi: 10.3390/antibiotics10091031.